Why you can't compare Covid-19 vaccines
What a vaccine's "efficacy rate" actually means.
Subscribe to our channel! http://goo.gl/0bsAjO
In the US, the first two available Covid-19 vaccines were the ones from Pfizer/BioNTech and Moderna. Both vaccines have very high "efficacy rates," of around 95%. But the third vaccine introduced in the US, from Johnson & Johnson, has a considerably lower efficacy rate: just 66%.
Look at those numbers next to each other, and it's natural to conclude that one of them is considerably worse. Why settle for 66% when you can have 95%? But that isn't the right way to understand a vaccine's efficacy rate, or even to understand what a vaccine does. And public health experts say that if you really want to know which vaccine is the best one, efficacy isn't actually the most important number at all.
Further reading from Vox:
Why comparing Covid-19 vaccine efficacy numbers can be misleading: https://www.vox.com/22311625/covid-19-vaccine-efficacy-johnson-moderna-pfizer
The vaccine metric that matters more than efficacy: https://www.vox.com/22273502/covid-vaccines-pfizer-moderna-johnson-astrazeneca-efficacy-deaths
The limits of what vaccine efficacy numbers can tell us: https://www.vox.com/21575420/oxford-moderna-pfizer-covid-19-vaccine-trial-biontech-astrazeneca-results
Vox.com is a news website that helps you cut through the noise and understand what's really driving the events in the headlines. Check out http://www.vox.com.
Watch our full video catalog: http://goo.gl/IZONyE
Follow Vox on Facebook: http://goo.gl/U2g06o
Or Twitter: http://goo.gl/XFrZ5H
Видео Why you can't compare Covid-19 vaccines канала Vox
Subscribe to our channel! http://goo.gl/0bsAjO
In the US, the first two available Covid-19 vaccines were the ones from Pfizer/BioNTech and Moderna. Both vaccines have very high "efficacy rates," of around 95%. But the third vaccine introduced in the US, from Johnson & Johnson, has a considerably lower efficacy rate: just 66%.
Look at those numbers next to each other, and it's natural to conclude that one of them is considerably worse. Why settle for 66% when you can have 95%? But that isn't the right way to understand a vaccine's efficacy rate, or even to understand what a vaccine does. And public health experts say that if you really want to know which vaccine is the best one, efficacy isn't actually the most important number at all.
Further reading from Vox:
Why comparing Covid-19 vaccine efficacy numbers can be misleading: https://www.vox.com/22311625/covid-19-vaccine-efficacy-johnson-moderna-pfizer
The vaccine metric that matters more than efficacy: https://www.vox.com/22273502/covid-vaccines-pfizer-moderna-johnson-astrazeneca-efficacy-deaths
The limits of what vaccine efficacy numbers can tell us: https://www.vox.com/21575420/oxford-moderna-pfizer-covid-19-vaccine-trial-biontech-astrazeneca-results
Vox.com is a news website that helps you cut through the noise and understand what's really driving the events in the headlines. Check out http://www.vox.com.
Watch our full video catalog: http://goo.gl/IZONyE
Follow Vox on Facebook: http://goo.gl/U2g06o
Or Twitter: http://goo.gl/XFrZ5H
Видео Why you can't compare Covid-19 vaccines канала Vox
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Can we get rid of Covid-19 forever?Why Mount Everest's height keeps changingHow Singapore Uses Science to Stay CoolmRNA vaccines, explainedThe bridge design that helped win World War IIThe phony health craze that inspired hypnotismThe Mysterious Origins of the NucleusVaccine side effects are actually a good thingWhy Jakarta is sinkingWall Street Week - Full Show (03/19/2021)Why Putin wants Alexei Navalny deadThe Astounding Physics of N95 MasksThe invention that fixed lighthousesHow highways make traffic worseThe Portal ParadoxWhy the American West is fighting for water protectionsCentre States 'India's Overall Percentage Of COVID-19 Vaccine Wastage Is 6.5%, Highest In Telangana'How museum gift shops decide what to sellWhy Your Second COVID Shot Might Be a Doozy | SciShow NewsFed's Efforts to Hold Down Rates Raises Inflationary Pressures: Dalio